| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,232,115
|
869,204
|
605,104
|
566,724
| | Cost of Revenue | 218,511 | 170,293 | 139,331 | 127,179 | | |
Gross Profit
|
1,013,604
|
698,911
|
465,773
|
439,545
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 74,593 | 78,630 | 52,976 | 49,510 |
|
Non Recurring | 1,199 | 35,468 | 6,683 |
-
|
|
Others | 540,475 | 407,775 | 274,347 | 254,480 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
397,337
|
177,038
|
131,767
|
135,555
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (204,137) | 280,434 | (143,270) | 304,200 |
|
Earnings Before Interest And Taxes | 193,200 | 457,472 | (11,503) | 439,755 |
|
Interest Expense | 140,998 | 140,135 | 59,174 | 52,977 |
|
Income Before Tax | 52,202 | 317,337 | (70,677) | 386,778 |
|
Income Tax Expense | 20,408 | 89,548 | (26,703) | 154,503 |
|
Minority Interest | (9,209) | (9,161) | (9,114) | (9,076) |
|
|
|
Net Income From Continuing Ops | 4,532 | 215,407 | (53,088) | 218,032 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
4,532
|
215,407
|
(53,088)
|
218,032
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
22,585
|
218,628
|
(53,088)
|
223,199
|
|
0.12%